Home > Financial Ratios > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SHUKRA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SHUKRA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.77238.70121.1264.8116.13

What is the latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS is -23.77 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-23.77
Mar2024238.70
Mar2023121.12
Mar202264.81
Mar202116.13

How is Core EBITDA Growth of SHUKRA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.77
Negative
Mar2024 238.7
97.08
Mar2023 121.12
86.88
Mar2022 64.81
301.80
Mar2021 16.13 -

Other Financial Ratios of SHUKRA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SHUKRA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS ₹1,549.7 Cr 11.1% -18% 61.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,150.0 Cr -0.9% -3.9% 1.3% Stock Analytics
DIVIS LABORATORIES ₹156,129.0 Cr -0.4% -7.6% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,312.0 Cr -2% -7.5% 27.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,445.2 Cr -1.5% -9.3% 3.8% Stock Analytics
CIPLA ₹98,210.2 Cr 1.7% -8.3% -16.8% Stock Analytics


SHUKRA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

11.1%

-18%

61.6%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses